883
Participants
Start Date
January 31, 2002
Primary Completion Date
January 31, 2006
Study Completion Date
September 30, 2008
Delayed ART
Participants follow a drug conservation (DC) regimen in which ART is stopped or deferred until CD4 cell count dropped below 250 cells/mm3, initiated until CD4 cell count is at least 350 cells/mm3, and then are followed by episodic ART based on CD4 cell count.
Continuous ART
Group 2 participants follow a viral suppression (VS) regimen in which ART was continued to keep viral loads as low as possible, regardless of CD4 cell count.
St. Vincent Hosp. & Med. Ctr. CRS, New York
Bronx Prevention Center CRS, The Bronx
Bronx-Lebanon Hosp. Ctr. CRS, The Bronx
Montefiore Med. Ctr., AIDS Ctr. CRS, The Bronx
Philadelphia FIGHT - Dr. Jay Kostman CRS, Philadelphia
Temple Univ. School of Medicine CRS, Philadelphia
Albert Einstein Med. Ctr., Immunodeficiency Ctr. CRS, Philadelphia
Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS, Washington D.C.
MediCorp, Infectious Disease Associates CRS, Fredericksburg
Hanover Med. Park (Mechanicsville, VA) CRS, Mechanicsville
Vernon Harris East End Community Health Ctr. CRS, Richmond
CrossOver Health Ctr. CRS, Richmond
South Richmond Health Care Ctr. CRS, Richmond
Hunter Holmes McGuire VAMC CRS, Richmond
VCU Health Systems, Infectious Disease Clinic CRS, Richmond
Eastern Virginia Med. School, Ctr. for the Comprehensive Care of Immune Deficiency CRS, Norfolk
Petersburg Health Care Alliance CRS, Petersburg
Atlanta VAMC CRS, Decatur
Miami VAMC CRS, Miami
Harper Hosp., Detroit CRS, Detroit
Wayne State Univ. CRS, Detroit
Wayne State Univ. INSIGHT CRS, Detroit
Detroit Community Health Connection, Inc. CRS, Detroit
McAuley Health Ctr. CRS, Grand Rapids
Western Infectious Disease Consultants CRS, Wheat Ridge
Denver Public Health CRS - INSIGHT, Denver
Denver Public Health CRS, Denver
Eastside Family Health Ctr. CRS, Denver
Denver VAMC CRS, Denver
AIDS Healthcare Foundation CRS, Beverly Hills
UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS, Fresno
Dr. Shawn Hassler Med. Practice CRS, San Francisco
Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS, San Francisco
Castro-Mission Health Ctr. CRS, San Francisco
San Francisco VAMC, Infectious Diseases Clinic CRS, San Francisco
UCSF PHP, Gen. Internal Medicine Practice CRS, San Francisco
Dr. Robert Scott Med. Practice CRS, Oakland
East Bay AIDS Ctr. CRS, Oakland
Multnomah County Health Dept., HIV Health Services Ctr. CRS, Portland
Legacy Clinic Good Samaritan CRS, Portland
The Research & Education Group-Portland CRS, Portland
Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS, Portland
Kaiser Immune Deficiency Clinic of Portland CRS, Portland
Legacy Clinic Emanuel CRS, Portland
Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS, Portland
PeaceHealth Med. Group - Hilyard Street Clinic CRS, Eugene
Dr. M. Estes Med. Practice CRS, Mill Valley
Dr. Virginia Cafaro Med. Practice CRS, San Francisco
Dr. William Owen Med. Practice CRS, San Francisco
Beacon Clinic at Boulder CRS, Boulder
Denver Infectious Diseases Consultants CRS, Denver
Kaiser Permanente of Denver CRS, Denver
Univ. of Colorado Health Science Ctr. CRS, Denver
Cooper Univ. Hosp. CRS, Camden
Cooper Hospital/Univ. Med. Ctr., The Cooper Early Intervention Program (EIP) CRS, Camden
New Jersey Medical School- Adult Clinical Research Ctr. CRS, Newark
South Jersey Infectious Disease, Cape Clinical Trials CRS, Somers Point
The Early Intervention Program at Kennedy Hosp. CRS, Voorhees Township
Community Programs for Clinical Research on AIDS
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH